News
Eli Lilly's Mounjaro and Zepbound drove Q2 2025 revenue up 38% and EPS up 92% YoY. Read why LLY stock's recent 20% pullback ...
4h
The Observer on MSNLow prices and tariff threats test Big Pharma’s ties to UK
AstraZeneca chief is irked by cost of doing business as Eli Lilly raises price of Mounjaro after presidential pressure ...
Eli Lilly and Company (NYSE:LLY)’s pipeline has been advancing, thanks to positive study results in oncology and ...
Eli Lilly and Company (NYSE:LLY) is one of the best growth stocks to buy according to analysts. On August 14, Eli Lilly and ...
Major pharmaceutical companies raised concerns about Ireland’s competitiveness, ahead of Donald Trump’s opening shots in early April which began the tariff war with the EU.
Alexa Bliss currently holds the WWE Women's Tag Team Championship alongside Charlotte Flair. The Queen and The Goddess made their presence felt on SmackDown this week.
19h
TipRanks on MSNEli Lilly’s Stock Soars Amid Promising Trials
Eli Lilly & Co ( ($LLY) ) has risen by 10.63%. Read on to learn why. Eli Lilly & Co has seen a notable increase in its stock price, rising ...
Wall Street loves a dominant player, and Eli Lilly (NYSE: LLY) looks unstoppable with its obesity blockbusters printing money ...
Eli Lilly Vs. Novo Nordisk: Correction Overly Done - GLP-1 Market Leadership/ Robust Pipelines Ahead
Novo Nordisk's (NVO) corrections amid AI market rotation might be an opportunity, due to GLP-1 market leadership & balanced ...
As the cost of Mounjaro jabs is set to increase by as much as 170 per cent, Jade Kay, who has already spent £2.4k on the drug ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results